ABSTRACT Background Hospital admission rates for chronic obstructive pulmonary disease (COPD) are known to be strongly associated with population factors. Primary care services may also affect admission rates, but there is little direct supporting evidence. Objectives To determine associations between population characteristics, diagnosed and undiagnosed COPD prevalence, primary healthcare factors, and COPD admission rates primary care trust (PCT) and general practice levels in England. Design, setting, and participants National crosssectional study (53,676,051 patients in 8,064 practices in 152 English PCTs), combining data on hospital admissions, populations, primary healthcare staffing, clinical practice quality and access, and prevalence. Main outcome measures Directly and indirectly standardised hospital admission rates for COPD, for PCT and practice populations. Results Mean annual COPD admission rates per 100 000 population varied from 124.7 to 646.5 for PCTs and 0.0 to 2175.2 for practices. Admissions were strongly associated with population deprivation at both levels. In a practice-level multivariate Poisson regression, registered and undiagnosed COPD prevalence, smoking prevalence and deprivation were risk factors for admission (p<0.001
INTRODUCTION
Around 210 million people have chronic obstructive pulmonary disease (COPD) worldwide. 1 The WHO has estimated that there will be a 30% increase in COPD deaths in the next 10 years and that COPD will become the third leading cause of death by 2030. 2 The natural history of COPD involves gradual deterioration in lung function, marked by exacerbations requiring primary care intervention or hospital admission, a gradual decline in quality of life and reduced life expectancy. 3 The total annual cost of COPD to the English National Health Service (NHS) is over £800 million (US$1215 million), and it has become the second largest cause of emergency hospital admissions in the UK. 4 The Department of Health (DH) for England has released a COPD national strategy 5 and it also has a range of policies to improve longterm condition management in primary care, with the aim of improving quality and length of life and reducing hospital admissions. For example, it has introduced a 'pay for performance' programme, the Quality and Outcomes Framework (QOF), which rewards general practices for identifying (by registering on practice computer systems) and managing effectively (by achieving a number of evidence-based quality indicators) a number of long-term conditions, including COPD. As a result, national data are available on registered prevalence and indicator achievement for almost all practices. 6 Over three quarters of a million people are on general practice COPD registers in England, but a mathematical prevalence model estimates that the actual number with the disease is about 1.2 million. 7 Reducing unnecessary hospital admissions will play a critical role in ensuring the NHS and other health systems meet the challenge of real terms reductions in resourcesdthe 2010 UK Budget report factors in potential savings of £2.4 billion from this source. 8 COPD is one of a number of ambulatory or primary care sensitive (PCS) conditions, for which it is hypothesised that risk of hospital admission will be reduced by effective primary care management. 9e11 However, PCS conditions have mainly been identified by expert opinion rather than empirically. 12 13 Previous research has also been hampered by lack of detailed data about practice populations and the quality of primary care services, such as is now available through QOF, or has been carried out only at primary care trust (PCT) level (PCTs are NHS organisations responsible for groupings of practices in geographic areas). Some population factorsdespecially deprivationd are strongly associated with PCS condition admission rates, and there are weaker associations with primary care access and supply factors. Effective management of COPD may reduce the risk of hospital admission. Godtfredsen et al found a gradient of RR of hospital admission with increasing smoking prevalence. 18 In addition, combination treatment with long-acting beta-agonists and inhaled corticosteroids reduces the annual rate of COPD exacerbations and improves health status and spirometric values. 19 20 A systematic review demonstrated that patients with COPD who received interventions with two or more components of the Chronic Care Model had lower rates of hospitalisations. 21 The aim of this study was to examine the associations between population characteristics, including both diagnosed and undiagnosed prevalence, primary healthcare factors, and COPD admission rates at PCT and practice levels in England. Both levels of analysis are desirable, as aggregation to PCT level could mask important associations present at practice level. Specific objectives were first to investigate the associations between rates of hospital admission for COPD and population factors (deprivation, smoking prevalence, QOF registered/diagnosed prevalence rates and undiagnosed, ie, expected minus QOF registered prevalence rates). The second objective was to investigate associations between admission rates and a range of healthcare factors, after adjustment for population factors. These included access factors (general practitioner (GP) and practice nurse supply and QOF access indicators), COPD-specific QOF quality indicators, and smoking cessation advice or referral, to explore their relative impacts. As all UK residents are entitled to primary care consultations which are free at the point of use, and as the vast majority of residents are registered with a practice, there are no apparent barriers to access. However, despite NHS resources being allocated on a needs-weighted population basis, there are quite wide variations in access as measured by patients' experience of the availability of unscheduled care and appointmentsdhence the inclusion of these indicators in QOF. (table 1) . We used the number of COPD patients recorded by general practices (registered prevalence), the total list sizes of patients per practice as denominators (the definition used by the Information Centre), the total QOF points achieved for the COPD domain and individual indicators for specific COPD care (ie, spirometric confirmation of diagnosis, recent record of forced expiratory volume in one second (FEV 1 ), inhaler technique and influenza immunisation offered). Since stopping smoking affects the prognosis of COPD, we also included the percentage of patients with a chronic disease whose notes record that smoking cessation advice or referral to a specialist service has been offered within the previous 15 months (Smoking 4). To measure broad access to care from the patient perspective we used two new patient experience (PE) indicators introduced in the 2008e2009 QOF, which were derived from the results of the national GP Patient Survey, and which measure ability to access a GP consultation within 2 days (PE7), and ability to book an appointment with a GP more than 2 days ahead (PE8).
METHODS

Hospital episodes statistics data
Practice staffing
The Health and Social Care Information Centre provided data on GP and nurse supply (GPs and practice nurses per 100 000 population), at practice and PCT levels, respectively, as of September 2007. 22 Practice nurse numbers do not include other nurses working in the community, such as 'community matrons' or district nurses, who may have contact with COPD patients.
Undiagnosed prevalence data
We used practice-level predictions of COPD prevalence from the Association of Public Health Observatories website, which uses a model developed by Nacul et al 
Statistical analysis
The basic unit of analysis was the general practice population. Indirect standardisation is generally accepted as more robust when counts are relatively small, so indirectly standardised admission rates were calculated at the practice level, to produce overall expected admission rates for each practice based on the England age/sex specific rates. These were compared to the observed practice-level admission numbers. Baseline PCT characteristics were then calculated including registered population (the sum of registers of general practices located within PCTs' geographic boundaries), age distribution, IMD, practices per PCT and practice list size. Practice level characteristics (QOF points and indicator breakdown) were aggregated to PCT level, as required. As admission counts were larger at PCT level, directly standardised (age and sex) admission rates were calculated per 100 000 GP registered population, using the total England population as the standard with which to weight the PCT rates. Three-year averages of registered and estimated COPD prevalences were summarised and undiagnosed prevalence calculated.
At practice and PCT levels, bivariate associations between admission rates and the above continuous independent variables were first assessed using Spearman's correlation coefficient. For the PCT level analysis, least-squares linear multivariate regression models were then fitted to examine the effects of all independent variables. At the practice level, because of low admission numbers, we applied Poisson regression, where standard errors have been scaled using the square root of the deviance-based dispersion. The dependent variable was observed count of hospital admissions and the offset was the expected number of admissions. Poisson regression returns incidence rate ratios (IRRs), which in this context can be considered as analogous to ORs. Microsoft Excel and Access were used to manage the data and the software package Stata10 was used for all statistical analysis.
RESULTS
The 152 English PCTs had a total GP-registered population of 53 547 488 patients (table 2). The GP-registered population in each PCT varied from 94 635 to 1 294 596 (mean 352 286). We were able to match all the data required for 8064 (90.3%) GP practices from a total of 8932. List size varied from 984 to 38 343 (mean 6603). Estimated smoking prevalence at practice level varied from 13.2% to 51.7%. QOF scores achieved were generally high, for influenza immunisation, inhaler technique and spirometry, although there was a wider variance in PCTs recording spirometry (76.0e96.4%) and recording FEV 1 (75.5e89.3%). The range of QOF Patient Experience scores also tended to be lower. Table 3 summarises the observed, estimated and calculated undiagnosed prevalence levels for COPD at the PCT and practice level. The England mean prevalence of registered COPD in the whole population is 1.5% (SD 0.0%), and undiagnosed COPD is 2.2% (SD 0.1%). Mean (over 3 years) annual hospital admission rates for COPD per 100 000 population varied from 124.7 to 646.5 (median 241.5, IQR 178.1e331.4) at PCT level and 0.0 to 2175.2 (median 179.0, IQR 111.1e288.2) at general practice level, illustrating the greater variance observable in a practice level analysis. Over 98% of admissions were in the 45 years and over age group.
Regression modelling
In the bivariate regression of exposure variables against hospital admission rates at PCT level, deprivation and smoking prevalence were the variables with highest explanatory power, accounting for 59.3% and 51.4% of the total variance, respectively (p<0.001). Estimated prevalence accounted for 45.1% of the variance (p<0.001) compared to the observed (registered) COPD prevalence (21.9%, p<0.001). About 14.4% of the variance in hospital admissions was explained by GP supply (p<0.001). The QOF COPD overall clinical quality score was shown to account for only 2.1% of the variance (p¼0.034). Among all specific clinical QOF indicators, the score for influenza immunisation showed the highest explanatory capacity (6.9%, p<0.001). In the multivariate regression model using reverse stepwise variable selection (R 2 ¼75.0%), the undiagnosed disease prevalence as well as all QOF clinical indicators were not retained in the model using a probability criterion of 0.1 (table 4) . Table 4 also shows the practice-level analysis using Poisson regression with reverse stepwise variable selection. The highest IRR was estimated for observed prevalence (IRR¼1.224, p<0.001), and undiagnosed prevalence, deprivation, smoking prevalence, GP supply and access to a GP consultation, and influenza immunisation status were also retained in the final model using reverse stepwise variable selection and a probability criterion of 0.1. Overall COPD score, and clinical quality indicators COPD 10, COPD 11, COPD 12 and Smoking 4 all dropped out of this model. 
Patient experience indicators PE7 Patient experience of access (1)
The percentage of patients who, in the appropriate national survey, indicate that they were able to obtain a consultation with a GP (in England)
70e90%
PE8 Patient experience of access (2)
The percentage of patients who, in the appropriate national survey, indicate that they were able to book an appointment with a GP more than 2 days ahead 35 60e90%
*The lower and upper achievement levels required to receive the minimum and maximum payment. CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; GP, general practitioner; TIA, transient ischaemic attack.
DISCUSSION
In this cross-sectional study of hospital admissions for COPD, registered COPD prevalence, undiagnosed prevalence, smoking prevalence and deprivation were all risk factors for hospital admission (p<0.001). Primary healthcare factors such as being offered influenza immunisation, patient-reported access to primary care consultations within 2 days, and primary care supply (GPs and practice nurses per 100 000 population) were protective factors (p<0.05). There was an overall consistency in the findings at organisation and practice levels, but with additional independent variables being retained in the practice level model and with stronger associations apparent. At practice level, after adjustment for deprivation, undiagnosed COPD prevalence as well as diagnosed disease was strongly associated with the rate of hospital admission. Primary healthcare factors such as being offered influenza immunisation, patient-reported good access to GP consultation, and GP and practice nurse supply were also significantly associated with reduced hospital admission rates.
Hospital admissions for COPD were strongly associated with deprivation scores and smoking prevalence at both PCT and practice level. This relationship has been documented previously, 25 26 but associations with primary care supply less often. Saxena et al studied the association at London PCT level between population and practice factors with hospital admission rates for PCS conditions (including COPD). 17 They found some associations between primary healthcare factors and admission rates, but not with practice resourcing. By contrast, a practice level analysis of hospital admissions for asthma in East London found that practice characteristics were the strongest predictor of the admission rate, but the most likely explanation for this result could be that the geographically small region under investigation was uniformly deprived. 16 In our study, GP supply was inversely associated with hospital admission rates at the practice (but not PCT) level. Conversely, practice nurse supply was associated with lower admission rates at PCT level, but unfortunately these data are not readily available at practice level. These and similar findings, together with the impacts demonstrated in our QOF indicator analysis, highlight the need for adequate primary care provision in deprived areas. Geographical inequalities in GP supply have been persistent despite needs-based funding of PCTs.
27
Our study was strengthened by using data from a national population, giving a high level of statistical power, and by combining practice-level data and estimates from a number of sources which were previously unavailable or only available locally. This revealed associations which may have been masked in previous studies which used the organisation as the level of analysis. This study is also the first to examine estimates of undiagnosed disease and its association with hospital admissions.
The BTS definition of COPD used for the prevalence estimates is stringent, which may lead to underestimation of the effect of undiagnosed disease prevalence. Conversely, the COPD model does not include lack of bronchodilator responsiveness in the definition of COPD, so this will slightly overestimate prevalence. We were able to include several new QOF clinical quality and patient experience indicators. Our analysis also illustrates the greater benefits of using practice level rather than organisation level data. Our findings would be strengthened by similar analyses of other long-term conditions, which would also validate the selection of PCS conditions, and assist in regulation of primary care.
There are several limitations. Hospital or general practice diagnostic coding may be incorrect. However, the advent of diagnosis-based payment of hospitals has accelerated improvement in data quality. We only considered primary or principal diagnosis, and 87.2% of primary diagnoses for hospital admissions in England are coded correctly. 28 Counts of annual hospital admissions per practice were relatively low, even using means of 3 years' data (mean per year¼12.9, median per year¼10.0). We used appropriate methods (indirect standardisation and Poisson regression) to deal with this, and were reassured by the overall consistency between the results at organisation and practice levels. Furthermore, a number of UK agencies use practice-level admission data to support commissioning and quality improvement, so its use should prompt similar scrutiny to that which followed use of similar data at hospital level. In the case of COPD, general practices may add patients to COPD registers without necessary confirmatory spirometrydonly 82.4% have a record of this test. This will overestimate the correctly diagnosed prevalence.
Reported practice populations may overestimate actual numbers, especially in urban areas with high mobility. Conversely, a small number of residents may not be registered with a practice. There is also a high level of achievement of many QOF indicators which results in a 'ceiling effect', which may reduce the ability to detect real differences in clinical quality. Many QOF indicators measure care processes which may not be strongly related to disease outcomes (as our analysis suggests). The impact of recent changes in quality of care on outcomes such as hospital admission may be delayed, but changes in QOF scores between 2005 and 2007 were small. Other data inevitably covered slightly different periods and dates. HES data do not include privately funded hospital admissions, but the vast majority of unplanned admissions for COPD are to NHS hospitals. We did not analyse readmissions separately as the focus was on factors affecting exacerbations in the community. Practice-level COPD and smoking prevalence estimates are based on the limited range of risk factor data available locally.
There are now several disease prevalence models for England which enable comparisons of QOF-registered and expected prevalence counts. We showed an association between admission rates and undiagnosed prevalence. The National COPD Audit has shown that 90% of those hospitalised with COPD were known to have the diagnosis before admission and to suffer exacerbations frequently. 29 However, a population survey from Spain showed a high rate of undiagnosed COPD, and significant impairment in health-related quality of life and activities of daily living in undiagnosed individuals. 30 Patients who have frequent exacerbations irrespective of disease severity may represent a distinct COPD phenotype, implying that earlier diagnosis and intervention may improve outcomes. 31 The validity of the model, and the cost-effectiveness of targeted COPD case-finding strategies in practices with high estimates of undiagnosed disease, should therefore be evaluated.
The new QOF Patient Experience indicators were introduced, as their title suggests, to improve patient satisfaction with access to primary healthcare. However, the strong association between these indicators and admission rates suggests that they also reflect clinically important aspects of access. The National COPD Audit showed that 74% of admitted patients make contact with their general practice in the month before admission and 31% have three or more contacts in those 4 weeks. 29 Given that the ability to access primary care rapidly during a COPD exacerbation may well reduce admission risks, the association with PE7, the ease of obtaining a consultation, is plausible. That there is also an association with PE8, the ease of making non-urgent appointments, and with GPs per 100 000 practice population, suggests that access barriers may also affect ongoing COPD management.
At practice level, only QOF COPD indicator 8, uptake of influenza immunisation, was associated with hospital admission rates. This is clinically plausible. The other QOF COPD indicators are measures of clinical processes and standards which are less likely to affect outcomes. Alternatives which are more likely to affect outcomes should be considered. For example, practices could be incentivised to deliver more intensive smoking cessation services to COPD patients. The updated NICE COPD guidelines currently out for consultation recommend that pulmonary rehabilitation should be made available to all appropriate patients with COPD, and that newer long-acting drugs be prescribed to appropriate patients. 32 The interventions in the Chronic Care Model reduce admission rates, although they are difficult to measure. 21 Finally, other factors which could affect admission rates include the quality of out of hours services, the presence of specialist nurse services, and the supply and quality of hospital services.
